Pay in 4 interest-free payments of $5.63 Learn more
Ships within 48 hours · Estimated delivery Oct 12 - Oct 17
Unlike GLP-1 agonists such as semaglutide or tirzepatide, which work primarily through appetite suppression, AOD-9604 directly enhances fat metabolism at the cellular level through beta-3 adrenergic receptor modulation
The peptide did not produce adverse metabolic effects associated with full-length growth hormone, including insulin resistance, glucose intolerance, or IGF-1 elevation
Batchspecific Certificates of Analysis (COAs) included
Insert the needle into the vial without pushing or pulling the plunger
Handle it with care to avoid contamination or degradation of the peptide
The lyophilized vial format provides a stable research presentation that supports long-term storage, analytical consistency, and reproducibility across laboratory investigations
US$ 21.94
US$ 28.74
US$ 20.72
US$ 22.50
US$ 21.16
US$ 23.35
US$ 21.12
US$ 20.07
